- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/88 - Oxygen atoms
Patent holdings for IPC class C07D 239/88
Total number of patents in this class: 297
10-year publication summary
|
21
|
14
|
23
|
26
|
18
|
22
|
15
|
18
|
8
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 175 |
10 |
| Pfizer Inc. | 3386 |
8 |
| The Trustees of Columbia University in the City of New York | 3589 |
7 |
| Exelixis, Inc. | 401 |
7 |
| Gilead Sciences, Inc. | 2056 |
7 |
| Merck Sharp & Dohme LLC | 3753 |
6 |
| Hoffmann-La Roche Inc. | 3478 |
5 |
| Abbvie Inc. | 1806 |
5 |
| NY State Psychiatric Institute | 7 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 766 |
4 |
| Ache International (BVI) Ltd. | 6 |
4 |
| Ache Laboratorios Farmaceuticos S.A. | 22 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2596 |
4 |
| prAna Biotechnology Limited | 13 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
4 |
| Kala bio, Inc. | 45 |
4 |
| Bristol-myers Squibb Company | 4849 |
3 |
| BASF SE | 21017 |
3 |
| Janssen Pharmaceutica N.V. | 3367 |
3 |
| AbbVie Biotechnology Ltd. | 174 |
3 |
| Other owners | 197 |